Harvard University has long played an outsized role in spurring the growth of the Boston area’s life sciences industry, but the school’s contributions have largely unfolded behind the scenes.
Unlike the Massachusetts Institute of Technology in Cambridge’s Kendall Square — the beating heart of biotech — Harvard has been known less for spinning off startups than for licensing cutting-edge research and grooming the industry’s business leaders.
A trio of scientists have started working with researchers at GlaxoSmitKline on a potential cure for cancer. In fact, they believe they’ve found the diseases’ “Achilles heel.”
Last month, GlaxoSmithKline (NYSE: GSK) selected a Wistar/Penn project for its 2014 Discovery Fast Track Challenge program, which was created to accelerate the development of new medicines.
A Exciting Opportunity for Investor Meetings and Showcases
SUBMISSION DEADLINE: January 21, 2015
We invite you to submit your high-growth and innovative companies to individually meet with and showcase to an exclusive Global 1000 Transaction Network of Corporate Investors, Venture Capitalists, and Angel Investors at the Combined University Startups and Global 1000 Meet | Partner | Deal Conference in Washington, DC, on March 11 and 12, 2015.
The United States shouldn’t worry just yet about losing the number one spot as far as disease-related research in the world goes – that’s pretty solid – but that doesn’t mean the country is steadily moving forward the way it could or should.
‘Tis the season for dieting and purchasing gym memberships you may or may not use.
There are plenty of tactics out there for how to drop excess weight fast, and generally speaking, most of them probably won’t be the quick fix resolutionaries are hoping for (yes, that’s a made up word).
In 2012, we authored a report titled The Evolving Business Case for Social Media in Healthcare – a publication covering the range of social media influences on the industry. These influences were essentially cloud-based approaches to sharing information between consumers, individual care professionals and healthcare organizations.
The Colonial Room of the St. Francis Hotel in San Francisco was filled beyond capacity Monday afternoon, and the offices of digital-health seed fund Rock Health were buzzing with hundreds of partygoers just a couple of hours later.
Swiss drugmaker Roche said on Wednesday it had entered into an agreement with QIAGEN that includes a provision of non-exclusive licenses to recently granted Roche patents, pertaining to the detection of mutations in the EGFR pathway.
In a laboratory first, Duke researchers have grown human skeletal muscle that contracts and responds just like native tissue to external stimuli such as electrical pulses, biochemical signals and pharmaceuticals.
It didn’t take R. Michael Gill very long to come up with some priorities after Gov.-elect Larry Hogan named him the next Maryland Department of Business and Economic Development secretary last week.
Gill wants to keep McCormick & Co. Inc. (NYSE: MKC) in state. He wants to bring the FBI headquarters to Maryland. And he wants to emphasize customer service in dealing with businesses.
